Inactive Instrument

Company Mylan Inc Nasdaq

Equities

US6285301072

Pharmaceuticals

End-of-day quote Nasdaq
- USD 0.00% Intraday chart for Mylan Inc

Business Summary

Viatris Inc. (Viatris) is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of its operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, as well as the Company's ARV franchise. Its portfolio comprises over 1,400 approved molecules across a range of key therapeutic areas, including key brands and complex generics. It operates around 40 manufacturing sites worldwide, which produce oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients. Its products include Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen Auto Injector, Fraxiparine and Yupelri.

Sales per Business

USD in Million2022Weight2023Weight Delta
Brands
63.7 %
9,890 60.8 % 9,801 63.7 % -0.90%
Generics
36.3 %
5,015 30.8 % 5,588 36.3 % +11.42%

Sales per region

USD in Million2022Weight2023Weight Delta
Developed Markets
37.0 %
5,844 35.9 % 5,700 37.0 % -2.46%
United States
23.1 %
3,947 24.3 % 3,552 23.1 % -10.00%
Emerging Markets
16.6 %
2,637 16.2 % 2,552 16.6 % -3.24%
China
12.3 %
1,951 12.0 % 1,889 12.3 % -3.19%
Japan, Australia and New Zealand
9.3 %
1,634 10.0 % 1,425 9.3 % -12.81%
Greater China
1.8 %
250 1.5 % 271 1.8 % +8.60%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 22-12-28
President 63 20-11-15
Compliance Officer - 20-11-15
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - Dec. 14
Chief Operating Officer - 20-11-15
Chief Tech/Sci/R&D Officer - -
Public Communications Contact - 20-11-15
Investor Relations Contact - 20-10-31
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Chairman 56 20-11-15
Director/Board Member 68 20-11-15
Director/Board Member 66 20-11-15
Director/Board Member 76 20-11-15
Director/Board Member 62 22-12-28
Director/Board Member 63 20-11-15
President 63 20-11-15
Chief Executive Officer 61 22-12-28
Director/Board Member 60 20-11-15
Director/Board Member 70 20-11-15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,208,808,670 1,183,768,927 ( 97.93 %) 21,239,521 ( 1.757 %) 97.93 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
11.86 %
142,264,631 11.86 % 1 760 M $
BlackRock Advisors LLC
5.914 %
70,951,397 5.914 % 878 M $
Davis Selected Advisers LP
5.223 %
62,661,728 5.223 % 775 M $
61,923,920 5.162 % 766 M $
T. Rowe Price International Ltd.
4.123 %
49,465,753 4.123 % 612 M $
Invesco Advisers, Inc.
2.513 %
30,143,488 2.513 % 373 M $
Geode Capital Management LLC
2.292 %
27,496,891 2.292 % 340 M $
Pacer Advisors, Inc.
1.738 %
20,853,234 1.738 % 258 M $
Ameriprise Financial Services LLC
1.726 %
20,703,195 1.726 % 256 M $
Deerfield Management Co. LP
1.656 %
19,863,484 1.656 % 246 M $

Company contact information

Viatris, Inc.

Robert J. Coury Global Center 1000 Mylan Boulevard

15317, Canonsburg

+724 514 1800

http://www.viatris.com
address Mylan Inc

Group companies

NameCategory and Sector
Utah Acquisition Sub, Inc.
Chemicals: Specialty